Pedigree in diagnostics
25.07.2015 - US-Belgian cancer Dx specialist MDxHealth SA has appointed Philip J. Ginsburg as its new Chief Medical Officer. In this role, Ginsburg will have responsibility for the clinical strategy of the Herstal-based company that provides actionable epigenetic information to personalise the diagnosis and treatment of cancer.
Before joining MDxHealth, Ginsburg worked as CMO at Toma Biosciences and as President at Arista, a personalised medicine division of Iris International, Inc. later acquired by Beckman. Prior to that, he was CEO and co-founder of molecular Dx lab AlliedPath, which was ultimately acquired by Iris. Ginsburg also served as Senior Medical Director at Gen-Probe, Inc. Dr. Ginsburg earned his medical degree at the University of Pretoria School of Medicine, South Africa, and later specialised in clinical pathology at the University of Witwatersrand and the South African Institute of Medical Research.http://www.european-biotechnology-news.com/people/bio-people/2015/philip-ginsburg.html